https://assets.capyfin.com/instruments/678fdc13234e27009c5d6034.png avatar
Select Medical
🇺🇸 NYSE:SEM
View Company
OverviewEarningsDividends
•
Dec 31, 2022

Select Medical Q4 2022 Earnings Report

Select Medical's Q4 2022 earnings increased slightly, with revenue up but net income down compared to the same quarter last year.

Key Takeaways

Select Medical Holdings Corporation reported a revenue increase of 1.4% to $1,581.5 million for the fourth quarter ended December 31, 2022. However, net income decreased to $37.7 million compared to $66.3 million for the same quarter prior year. Earnings per common share was $0.22 for the fourth quarter ended December 31, 2022, compared to $0.37 for the same quarter, prior year.

Revenue increased by 1.4% to $1,581.5 million compared to the prior year's quarter.

Income from operations increased by 12.0% to $86.9 million.

Net income decreased to $37.7 million, compared to $66.3 million in the same quarter the previous year.

Earnings per common share decreased to $0.22, compared to $0.37 in the same quarter the previous year.

Total Revenue
$1.58B
Previous year: $1.56B
+1.3%
EPS
$0.22
Previous year: $0.37
-40.5%
Gross Profit
$173M
Previous year: $157M
+9.8%
Cash and Equivalents
$97.9M
Previous year: $74.3M
+31.8%
Total Assets
$7.67B
Previous year: $7.36B
+4.1%

Select Medical

Select Medical

Select Medical Revenue by Segment

Forward Guidance

Select Medical expects revenue to be in the range of $6.5 billion to $6.7 billion for the full year of 2023.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View Select Medical